Penetration of piperacillin and tazobactam into inflamed soft tissue of patients with diabetic foot infection

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 10, 2005, Pages 4368-4371

  Legat, F J ^a   Krause, R ^a   Zenahlik, P ^a   Hoffmann, C ^a   Scholz, S ^a   Salmhofer, W ^a   Tscherpel, J ^a   Tscherpel, T ^a   Kerl, H ^a   Dittrich, P ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

PIPERACILLIN; TAZOBACTAM; TAZONAM;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC FOOT; DISEASE DURATION; DRUG BLOOD LEVEL; DRUG PENETRATION; ESCHERICHIA COLI; EXTRACELLULAR SPACE; FEMALE; HUMAN; MALE; MICRODIALYSIS; OPEN STUDY; PRIORITY JOURNAL; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; DIABETIC FOOT; EXTRACELLULAR FLUID; FEMALE; HUMANS; INFLAMMATION; MALE; MICRODIALYSIS; MIDDLE AGED; PENICILLANIC ACID; PIPERACILLIN; SOFT TISSUE INFECTIONS;

EID: 25844444104     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.10.4368-4371.2005     Document Type: Article

References (15)

1. Caputo, G. M., P. R. Cavanagh, J. S. Ulbrecht, G. W. Gibbons, and A. W. Karchmer. 1994. Assessment and management of foot disease in patients with diabetes. N. Engl. J. Med. 331:854-860.
2. Chantelau, E. 1999. Zur Pathogenese der diabetischen Podopathie. Internist 40:994-1001.
3. Craig, W. A. 2003. Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid. Infect. Dis. Clin. N. Am. 17:479-501.
4. Dalla Costa, T., A. Nolting, A. Kovar, and H. Derendorf. 1998. Determination of free interstitial concentrations of piperacillin-tazobactam combinations by microdialysis. J. Antimicrob. Chemother. 42:769-778.
5. Frykberg, R. G. 2003. An evidence-based approach to diabetic foot infections. Am. J. Surg. 186:44-54.
6. Jeffcoate, W. J., and K. G. Harding. 2003. Diabetic foot ulcers. Lancet 361:1545-1551.
7. Joukhadar, C., H. Stass, U. Müller-Zellenberg, E. Lackner, F. Kovar, E. Minar, and M. Müller. 2003. Penetration of moxifloxacin into healthy and inflamed subcutaneous adipose tissues in humans. Antimicrob. Agents Chemother. 47:3099-3103.
8. Legat, F. J., A. Maier, P. Dittrich, P. Zenahlik, T. Kern, S. Nuhsbaumer, M. Frossard, W. Salmhofer, H. Kerl, and M. Muller. 2003. Penetration of fosfomycin into inflammatory lesions in patients with cellulitis or diabetic foot syndrome. Antimicrob. Agents Chemother. 47:371-374.
9. Müller, M., M. Brunner, U. Hollenstein, C. Joukhadar, R. Schmid, E. Minar, H. Ehringer, and H. G. Eichler. 1999. Penetration of ciprofloxacin into the interstitial space of inflamed foot lesions in non-insulin-dependent diabetes mellitus patients. Antimicrob. Agents Chemother. 43:2056-2058.
10. Muller, M., O. Haag, T. Burgdorff, A. Georgopoulos, W. Weninger, B. Jansen, G. Stanek, E. Agneter, H. Pehamberger, and H. G. Eichler. 1996. Characterization of peripheral compartment kinetics of antibiotics by in vivo microdialysis in humans. Antimicrob. Agents Chemother. 40:2703-2709.
11. Ocampo, A. P., K. D. Hoyt, N. Wadgaonkar, A. H. Carver, C. V. Puglisi. 1989. Determination of tazobactam and piperacillin in human plasma, serum, bile and urine by gradient elution reversed-phase high-performance liquid chromatography. J. Chromatogr. 496:167-179.
12. Perry, C. M., and A. Markham. 1999. Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections. Drugs 57:805-843.
13. Tassler, H., W. Cullmann, and D. Elhardt. 1993. Therapy of soft tissue infections with piperacillin/tazobactam. J. Antimicrob. Chemother. 31(Suppl. A):105-112.
14. Tomaselli, F., P. Dittrich, A. Maier, M. Woltsche, V. Matzi, J. Pinter, S. Nuhsbaumer, H. Pinter, J. Smolle, and F. M. Smolle-Jüttner. 2003. Penetration of piperacillin and tazobactam into pneumonic human lung tissue measured by in vivo microdialysis. Br. J. Clin. Pharmacol. 50:620-624.
15. Ungerstedt, U. 1991. Microdialysis-principles and applications for studies in animal and man. J. Intern. Med. 230:365-373.